XML 73 R45.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Organization (Details) - Schedule of Major Subsidiaries Consolidated | 12 Months Ended
--- | ---
Dec. 31, 2023
Aptorum Therapeutics Limited (“ATL”) [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Jun. 30, 2016
Ownership | 100.00%
Place of incorporation | Cayman Islands
Principle activities | Research and development of life science and biopharmaceutical products
APTUS MANAGEMENT LIMITED [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | May 16, 2017
Ownership | 100.00%
Place of incorporation | Hong Kong
Principle activities | Provision of management services to its holding company and fellow subsidiaries
Aptorum Medical Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Aug. 28, 2017
Ownership | 90.00%
Place of incorporation | Cayman Islands
Principle activities | Provision of medical clinic services
Paths Innovations Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Apr. 15, 2019
Ownership | 100.00%
Place of incorporation | Cayman Islands
Principle activities | Investment holding company
Paths Diagnostics Pte. Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Jun. 05, 2019
Ownership | 75.00%
Place of incorporation | Singapore
Principle activities | Research and development of life science and biopharmaceutical products
Acticule Life Sciences Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Jun. 30, 2017
Ownership | 80.00%
Place of incorporation | Cayman Islands
Principle activities | Research and development of life science and biopharmaceutical products
Claves Life Sciences Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Aug. 02, 2017
Ownership | 100.00%
Place of incorporation | Cayman Islands
Principle activities | Research and development of life science and biopharmaceutical products
Nativus Life Sciences Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Jul. 07, 2017
Ownership | 100.00%
Place of incorporation | Cayman Islands
Principle activities | Research and development of life science and biopharmaceutical products
Videns Incorporation Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Mar. 02, 2017
Ownership | 100.00%
Place of incorporation | Cayman Islands
Principle activities | Research and development of life science and biopharmaceutical products
Mios Pharmaceuticals Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Mar. 06, 2018
Ownership | 97.93%
Place of incorporation | Cayman Islands
Principle activities | Research and development of life science and biopharmaceutical products
mTOR (Hong Kong) Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Nov. 04, 2016
Ownership | 90.00%
Place of incorporation | Hong Kong
Principle activities | Research and development of life science and biopharmaceutical products
Scipio Life Sciences Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Jul. 19, 2017
Ownership | 97.93%
Place of incorporation | Cayman Islands
Principle activities | Research and development of life science and biopharmaceutical products
Signate Life Sciences Limited [Member] |
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] |
Incorporation date | Aug. 28, 2017
Ownership | 100.00%
Place of incorporation | Cayman Islands
Principle activities | Research and development of life science and biopharmaceutical products

X
- Definition Place of incorporation. + References No definition available. + Details
Name: | apm_EntityIncorporationsStateCountryName
Namespace Prefix: | apm_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Principle activities. + References No definition available. + Details
Name: | apm_PrincipleActivities
Namespace Prefix: | apm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date when an entity was incorporated + References No definition available. + Details
Name: | dei_EntityIncorporationDateOfIncorporation
Namespace Prefix: | dei_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_OwnershipAxis=apm_AptorumTherapeuticsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_APTUSMANAGEMENTLIMITEDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_AptorumMedicalLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_PathsInnovationsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_PathsDiagnosticsPteLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_ActiculeLifeSciencesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_ClavesLifeSciencesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_NativusLifeSciencesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_VidensIncorporationLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_MiosPharmaceuticalsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_mTORHongKongLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_ScipioLifeSciencesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_SignateLifeSciencesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |